Bionovo Announces Presentation on Its Lead Anti-Cancer Compound at Upcoming San Antonio Breast Cancer Symposium.

Publication: PR Newswire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2005 PR Newswire Association LLC

EMERYVILLE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Bionovo, Inc. (BULLETIN BOARD: BNVI) today announced that a poster presentation providing phase 1 results of its drug BZL101, in breast cancer, will be made on December 8 at the 28th Annual San Antonio Breast Cancer Symposium, which is taking place December 8-11 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. The presentation information is as follows:



Presentation Time: Thursday, December 8, 2005, 4:30 - 6:30 p.m. Location: Henry B....

Read the full article for free courtesy of your local library.